Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3068 Target Snapshot

Neuronal acetylcholine receptor subunit alpha-3 · SINGLE PROTEIN · Homo sapiens

73Compounds
15Assays
3Approved Drugs
51.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P32297. Use UniProt P32297 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P32297 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Neuronal acetylcholine receptor subunit alpha-3 as ChEMBL target CHEMBL3068, mapped to UniProt P32297. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Neuronal acetylcholine receptor subunit alpha-3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3068
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P32297
Neuronal acetylcholine receptor subunit alpha-3
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Neuronal acetylcholine receptor subunit alpha-3 is the right protein anchor across sources, using UniProt P32297 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNeuronal acetylcholine receptor subunit alpha-3
UniProt AccessionP32297
Component TypeProtein
Sequence Length505 aa

Neuronal acetylcholine receptor subunit alpha-3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Neuronal acetylcholine receptor subunit alpha-3, mapped to UniProt P32297. Sequence length is 505 aa.

Mapped IDP32297
Review nameNeuronal acetylcholine receptor subunit alpha-3
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

3
Approved
1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC5036.0
KI7.0
EC508.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL6623 8.15 EC50 7.0 Preclinical
CHEMBL309804 7.85 IC50 14.0 Preclinical
CHEMBL365956 7.81 IC50 15.6 Preclinical
CHEMBL3 7.35 IC50 45.0 Approved
CHEMBL430497 6.89 EC50 130.0 Clinical
CHEMBL2270633 6.75 IC50 180.0 Preclinical
CHEMBL3 6.66 Ki 220.0 Approved
CHEMBL334860 6.3 EC50 500.0 Preclinical
CHEMBL59986 6.16 EC50 700.0 Preclinical
CHEMBL1210515 6.0 IC50 1000.0 Preclinical
Distribution

pChEMBL Value Distribution

9
5.0
8
5.5
3
6.0
4
6.5
1
7.0
2
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

NICOTINE
CHEMBL3
Approved 1984
Assay Landscape

Assay Landscape

15
Total Assays
16
Tested Compounds
2
Assay Types
Binding — 9 assays, 16 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 6 14 5.9
single protein format 3 2 5.7
Functional — 6 assays, 15 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 6 15 5.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine